Diabetes monitoring systems for people with type 1 diabetes, type 2 diabetes, diabetes in pregancy addressing advisory systems for artificial pancreas research and patient engagement for continuous glucose monitoring (CGM). Invented the IoT in the field of diabetes sensors and biometrics in 2001.

Our diabetes programs have been designed over 15 years through the application of behavioral science and technology to effect behavior change.

​

In a recent study of a large Medicaid enhanced diabetes management program, Diabetech's program capabilities quickly determined that roughly 40% of those enrolled did not have sufficient risk our biometric data to warrant the State's high cost office visit based program. Subsequently, significant reductions in A1c were documented along with patient and provider satisfaction with Diabetech's AI-driven diabetes self-care program.

​

Learn more about the technology we use by clicking on Devices and Cloud Services.